Trametinib is a cancer drug. It is a MEK inhibitor drug with anti-cancer activity. 3d illustration

RFID:2BK5GXN

Image details

Contributor:

Igor Petrushenko / Alamy Stock Photo

Image ID:

2BK5GXN

File size:

60.8 MB (317 KB Compressed download)

Releases:

Model - no | Property - noDo I need a release?

Dimensions:

7000 x 3038 px | 59.3 x 25.7 cm | 23.3 x 10.1 inches | 300dpi

RFDP2RYF–Trametinib melanoma cancer drug

RFDP2RYG–Trametinib melanoma cancer drug

RF2BK5GXY–Trametinib is a cancer drug. It is a MEK inhibitor drug with anti-cancer activity. 3d illustration

RF2BK5GXW–Trametinib is a cancer drug. It is a MEK inhibitor drug with anti-cancer activity. 3d illustration

RF2BK5GXM–Trametinib is a cancer drug. It is a MEK inhibitor drug with anti-cancer activity. 3d illustration

RF2BK5GXT–Trametinib is a cancer drug. It is a MEK inhibitor drug with anti-cancer activity. 3d illustration

RF2BK5GY3–Trametinib is a cancer drug. It is a MEK inhibitor drug with anti-cancer activity. 3d illustration

RF2BK5GXX–Trametinib is a cancer drug. It is a MEK inhibitor drug with anti-cancer activity. 3d illustration

RF2BK5GY7–Trametinib is a cancer drug. It is a MEK inhibitor drug with anti-cancer activity. 3d illustration

RF2BK5GXR–Trametinib is a cancer drug. It is a MEK inhibitor drug with anti-cancer activity. 3d illustration

RF2BK5GXJ–Trametinib is a cancer drug. It is a MEK inhibitor drug with anti-cancer activity. 3d illustration